The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
710223328 7102233 28 F 200812 20160907 20090901 20160913 EXP PHHY2009CA22524 NOVARTIS 41.54 YR F Y 0.00000 20160913 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
710223328 7102233 1 PS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 20 MG, QMO 21008 20 MG /month
710223328 7102233 2 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 10 MG, QMO 21008 10 MG /month
710223328 7102233 3 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 20 MG, QMO (EVERY 4 WEEKS) 21008 20 MG /month
710223328 7102233 4 SS FISH OIL FISH OIL 1 Unknown U 0
710223328 7102233 5 SS MINT-TOPIRAMATE TOPIRAMATE 1 Unknown 25 MG, QD 0 25 MG QD
710223328 7102233 6 SS MINT-TOPIRAMATE TOPIRAMATE 1 Unknown 50 MG, QD 0 50 MG QD
710223328 7102233 7 SS MINT-TOPIRAMATE TOPIRAMATE 1 Unknown 100 MG, QD 0 100 MG QD
710223328 7102233 8 C SYNTHROID LEVOTHYROXINE SODIUM 1 Unknown 0.05 MG, UNK U 0 .05 MG
710223328 7102233 9 C CORTEF//HYDROCORTISONE 2 Unknown 30 MG, QD (20MG AM AND 10 MG PM) U 0 30 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
710223328 7102233 1 Acromegaly
710223328 7102233 4 Product used for unknown indication
710223328 7102233 5 Migraine
710223328 7102233 8 Product used for unknown indication
710223328 7102233 9 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
710223328 7102233 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
710223328 7102233 Abdominal discomfort
710223328 7102233 Abdominal pain upper
710223328 7102233 Amenorrhoea
710223328 7102233 Arthritis
710223328 7102233 Back pain
710223328 7102233 Blood growth hormone increased
710223328 7102233 Blood pressure diastolic decreased
710223328 7102233 Blood pressure diastolic increased
710223328 7102233 Cholelithiasis
710223328 7102233 Contusion
710223328 7102233 Cough
710223328 7102233 Depression
710223328 7102233 Diarrhoea
710223328 7102233 Ear infection
710223328 7102233 Fall
710223328 7102233 Fatigue
710223328 7102233 Headache
710223328 7102233 Heart rate decreased
710223328 7102233 Hepatic cyst
710223328 7102233 Injection site pain
710223328 7102233 Injection site pruritus
710223328 7102233 Jaw disorder
710223328 7102233 Migraine
710223328 7102233 Muscle spasms
710223328 7102233 Nasopharyngitis
710223328 7102233 Neck pain
710223328 7102233 Pain
710223328 7102233 Pyrexia
710223328 7102233 Rash
710223328 7102233 Rash generalised
710223328 7102233 Skin discolouration
710223328 7102233 Sneezing
710223328 7102233 Syncope
710223328 7102233 Urticaria
710223328 7102233 Uterine cyst
710223328 7102233 Vaginal haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
710223328 7102233 1 20060707 0
710223328 7102233 5 20140121 0